RxDoctor Payments Data

James Starrett, DO

Family Medicine · St. Louis, MONPI 1568811586

Payments from drug & device makers

$503in general payments, 2019–2025

Across 26 payments — averaging $19.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$114
  • Novo Nordisk$69
  • Johnson & Johnson$68
  • Amgen$54
  • Boehringer Ingelheim$50
  • Sanofi-aventis U.S. LLC$44
  • plus $105 from 7 others

What the payments were for

  • Food & beverage$503100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$503 in reported general payments places this provider in the 50th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$66,926
Medicare patients
181
Services billed
962

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban84$91,429
Enbrel MiniEtanercept11$80,988
OzempicSemaglutide46$65,892
JardianceEmpagliflozin45$54,718
Trelegy ElliptaFluticasone/Umeclidin/Vilanter53$46,993
XareltoRivaroxaban33$32,589
TrulicityDulaglutide26$26,600
FarxigaDapagliflozin Propanediol21$22,146
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr34$19,721
JanuviaSitagliptin Phosphate14$18,247
Spiriva RespimatTiotropium Bromide21$15,110
TradjentaLinagliptin18$10,078
Breo ElliptaFluticasone/Vilanterol18$7,718
Spiriva HandihalerTiotropium Bromide13$6,751
Atorvastatin Calcium742$6,697

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Abrysvo$14$94,64298 claims
Boehringer IngelheimJardiance, Spiriva Respimat, Tradjenta$50$79,90684 claims
Novo NordiskOzempic$69$65,89246 claims
Johnson & JohnsonXarelto$68$32,58933 claims
AstraZenecaFarxiga, Symbicort$24$26,94832 claims
Lilly USA, LLCTrulicity$12$26,60026 claims
MerckJanuvia$13$18,24714 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in St. Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →